Our Story

The Galileo Global Group (GGG) is an alliance of three independent firms. We share the same values; our offices are collocated, and we collaborate on a daily basis.

In October 2003, Georges Ugeux left the New York Stock Exchange, where he was Group Executive Vice President International and research, to create Galileo Global Advisors (GGA). The inspiration came from a need for independent advice that was becoming difficult to find since transactional objectives often drove the advisory role of investment banks. It was aimed at both private and public sector institutions.

As the firm’s activities developed, many clients asked for support in raising funds in the private capital market. Galileo Global Securities (GGS) was created to meet that demand. GGS is a broker-dealer registered with FINRA and owned and managed by Francois Pages. Over the years, this new company grew into a full-fledged investment banking firm specializing in cross-border transactions with an exclusive focus on small and mid-sized private assets.

More recently, Charles-André Brouwers added his management consulting expertise to the Galileo Global Group. He created Galileo Life Sciences (GLS), focusing on providing strategy, finance, and transaction support to the biopharmaceutical, medical, and health tech sectors.

At the Galileo Global Group’s core are shared values: senior expertise, global perspective, independent advice, and personal commitment to achieving our client’s strategic and financial objectives in the most optimal way

Founders

Georges Ugeux

CEO

galileo global advisors

Georges Ugeux is a lawyer and economist with over 30 years of experience in global business, government, and finance. He brings a strong understanding of cross-cultural negotiations and international partnerships. He also teaches International Banking & Finance as an adjunct faculty member at Columbia University.

François Pagès

CEO

galileo global securities

François Pagès has over 25 years of a strong International Banking experience with postings in Europe, Asia, and the Americas. Over the years he has been involved in creating numerous new businesses, reviewing and implementing acquisitions in the financial industry as well as managing teams of financial professionals.

Charles-André Brouwers

Managing Partner

galileo life sciences

Charles-André has thirty-year years of experience consulting to the biopharma and medical device industries. He worked closely with the CEOs, Senior Executives, and Boards of many Pharmaceutical and Medtech companies. Previous to founding Galileo Life Sciences, he was Senior Partner and Managing Director at the Boston Consulting Group and before Head of the Life Sciences Group of Capgemini.